Published in Curr Protoc Cytom on November 01, 2004
Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun (2003) 1.45
Expanded role for interleukin-17 in lyme arthritis: Comment on the article by Codolo et al. Arthritis Rheum (2009) 1.39
Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J Clin Microbiol (2008) 1.17
Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn Microbiol Infect Dis (2010) 1.14
C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease. Clin Diagn Lab Immunol (2003) 1.09
Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters. Clin Diagn Lab Immunol (2005) 1.06
Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immunol (2004) 1.06
Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol (2008) 1.02
CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection. Clin Diagn Lab Immunol (2005) 1.01
Ability of the borreliacidal antibody test to confirm lyme disease in clinical practice. Clin Diagn Lab Immunol (2002) 0.99
Cost-effective frozen master mix modification of a commercial methicillin-resistant Staphylococcus aureus PCR assay. J Clin Microbiol (2009) 0.98
Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin Diagn Lab Immunol (2003) 0.95
Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol (2007) 0.94
Cost-effective modification of a commercial PCR assay for detection of methicillin-resistant or -susceptible Staphylococcus aureus in positive blood cultures. J Clin Microbiol (2010) 0.94
Efficacy of bilateral bronchoalveolar lavage for diagnosis of ventilator-associated pneumonia. J Clin Microbiol (2009) 0.94
Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol (2011) 0.91
Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol (2008) 0.90
Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin Vaccine Immunol (2008) 0.89
Retrospective assessment of transcription-mediated amplification-based screening for Trichomonas vaginalis in male sexually transmitted infection clinic patients. J Clin Microbiol (2013) 0.89
Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection. J Clin Microbiol (2012) 0.89
One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol (2010) 0.89
Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice. FEMS Immunol Med Microbiol (2008) 0.88
Mechanisms to assess Gram stain interpretation proficiency of technologists at satellite laboratories. J Clin Microbiol (2007) 0.88
Hamster and murine models of severe destructive Lyme arthritis. Clin Dev Immunol (2012) 0.86
Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease. Clin Vaccine Immunol (2007) 0.85
Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol (2006) 0.85
Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area. Emerg Infect Dis (2006) 0.84
Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. FEMS Immunol Med Microbiol (2010) 0.83
The Emergence of Clinically Relevant Babesiosis in Southwestern Wisconsin. WMJ (2015) 0.82
Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production. Clin Vaccine Immunol (2006) 0.82
Human Lyme disease vaccines: past and future concerns. Future Microbiol (2009) 0.82
Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro. Clin Diagn Lab Immunol (2002) 0.82
Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community. Expert Rev Anti Infect Ther (2013) 0.82
Lyme disease in urban areas, Chicago. Emerg Infect Dis (2007) 0.81
Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice. Clin Diagn Lab Immunol (2004) 0.80
Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin. J Clin Microbiol (2011) 0.80
Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. J Microbiol Methods (2006) 0.79
Borrelia miyamotoi Infection in Patients from Upper Midwestern United States, 2014-2015. Emerg Infect Dis (2016) 0.78
ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602). Clin Cancer Res (2013) 0.76
Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro. Clin Vaccine Immunol (2006) 0.76
Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity. Clin Vaccine Immunol (2007) 0.75
Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis. Infect Immun (2013) 0.75
Circulating endothelial cells in patients with chronic lymphocytic leukemia. Ann Hematol (2008) 0.75
Isolation of moderately infectious Borrelia burgdorferi sensu stricto from attenuated cultures by using complement-mediated, antibody-dependent lysis selection technique in a mammalian tissue co-culture system. Microbes Infect (2003) 0.75
Identification of Escherichia coli O157:H7 surrogate organisms to evaluate beef carcass intervention treatment efficacy. J Food Prot (2010) 0.75